<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03518996</url>
  </required_header>
  <id_info>
    <org_study_id>201509731</org_study_id>
    <nct_id>NCT03518996</nct_id>
  </id_info>
  <brief_title>Non-Invasive Brain Stimulation and Delirium</brief_title>
  <official_title>Non-Invasive Brain Stimulation and Delirium</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether non-invasive brain stimulation can be used to
      improve cognitive deficits in patients with delirium.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Montreal cognitive assessment (MoCA)</measure>
    <time_frame>During the 1 week of treatment, with follow up 1 week</time_frame>
    <description>Change between pre- and post-intervention MoCA assessment (disease-specific symptom rating scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in brain rhythms</measure>
    <time_frame>During the 1 week of treatment, with follow up 1 week</time_frame>
    <description>Change from baseline EEG activity in participants receiving stimulation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium Observation Screening Scale (DOSS)</measure>
    <time_frame>During the 1 week of treatment, with follow up 1 week</time_frame>
    <description>Change between pre- and post-intervention DOSS assessment (disease-specific symptom rating scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium Rating Scale-R-98 (DRS)</measure>
    <time_frame>During the 1 week of treatment, with follow up 1 week</time_frame>
    <description>Change between pre- and post-intervention DRS assessment (disease-specific symptom rating scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)</measure>
    <time_frame>During the 1 week of treatment, with follow up 1 week</time_frame>
    <description>Change between pre- and post-intervention CAM-ICU assessment (disease-specific symptom rating scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mental Disorders</condition>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will receive 5 days of 3x daily rTMS targeted over the cerebellum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham rTMS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subjects will receive 5 days of 3x daily sham stimulation of the cerebellum.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Repetitive Transcranial Magnetic Stimulation (rTMS)</intervention_name>
    <description>Subjects with delirium and matched-controls will be receive theta frequency stimulation of the cerebellum. We will target the cerebellar vermis.</description>
    <arm_group_label>rTMS</arm_group_label>
    <other_name>rTMS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Repetitive Transcranial Magnetic Stimulation (rTMS)</intervention_name>
    <description>Subjects with delirium and matched-controls will be receive sham stimulation of the cerebellum. We will target the cerebellar vermis.</description>
    <arm_group_label>Sham rTMS</arm_group_label>
    <other_name>Sham stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A clinical diagnosis consistent with enrollment (positive for delirium)

        Exclusion Criteria:

          -  History of recurrent seizures or epilepsy

          -  Any other neurological or psychiatric diagnosis outside the diagnosis for which the
             participant is enrolled.

          -  Active substance use disorder in the past 6 months other than tobacco use disorder.

          -  Pacemaker

          -  Coronary Stent

          -  Defibrillator

          -  Neurostimulation

          -  Claustrophobia

          -  Uncontrolled high blood pressure

          -  Atrial fibrillation

          -  Significant heart disease

          -  Hemodynamic instability

          -  Kidney disease

          -  Pregnant, trying to become pregnant, or breast feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gen Shinozaki, MD, MS</last_name>
    <phone>(319) 384-4932</phone>
    <email>gen-shinozaki@uiowa.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kasra Zarei, MS</last_name>
    <phone>(319) 430-0869</phone>
    <email>kasra-zarei@uiowa.edu</email>
  </overall_contact_backup>
  <reference>
    <citation>Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009 Apr;5(4):210-20. doi: 10.1038/nrneurol.2009.24. Review.</citation>
    <PMID>19347026</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014 Mar 8;383(9920):911-22. doi: 10.1016/S0140-6736(13)60688-1. Epub 2013 Aug 28. Review.</citation>
    <PMID>23992774</PMID>
  </reference>
  <reference>
    <citation>Inouye SK. Delirium in older persons. N Engl J Med. 2006 Mar 16;354(11):1157-65. Review. Erratum in: N Engl J Med. 2006 Apr 13;354(15):1655.</citation>
    <PMID>16540616</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8.</citation>
    <PMID>2240918</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001 Dec 5;286(21):2703-10.</citation>
    <PMID>11730446</PMID>
  </reference>
  <reference>
    <citation>Marcantonio ER. Postoperative delirium: a 76-year-old woman with delirium following surgery. JAMA. 2012 Jul 4;308(1):73-81. doi: 10.1001/jama.2012.6857.</citation>
    <PMID>22669559</PMID>
  </reference>
  <reference>
    <citation>Flinn DR, Diehl KM, Seyfried LS, Malani PN. Prevention, diagnosis, and management of postoperative delirium in older adults. J Am Coll Surg. 2009 Aug;209(2):261-8; quiz 294. doi: 10.1016/j.jamcollsurg.2009.03.008. Epub 2009 May 1. Review.</citation>
    <PMID>19632604</PMID>
  </reference>
  <reference>
    <citation>Dyer CB, Ashton CM, Teasdale TA. Postoperative delirium. A review of 80 primary data-collection studies. Arch Intern Med. 1995 Mar 13;155(5):461-5. Review.</citation>
    <PMID>7864702</PMID>
  </reference>
  <reference>
    <citation>Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, Colantuoni C, Weinberger DR, Kleinman JE, Lipska BK. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet. 2012 Feb 10;90(2):260-72. doi: 10.1016/j.ajhg.2011.12.020. Epub 2012 Feb 2. Erratum in: Am J Hum Genet. 2012 Oct 5;91(4):765.</citation>
    <PMID>22305529</PMID>
  </reference>
  <reference>
    <citation>Sen P, Shah PP, Nativio R, Berger SL. Epigenetic Mechanisms of Longevity and Aging. Cell. 2016 Aug 11;166(4):822-839. doi: 10.1016/j.cell.2016.07.050. Review.</citation>
    <PMID>27518561</PMID>
  </reference>
  <reference>
    <citation>Tsai PC, Spector TD, Bell JT. Using epigenome-wide association scans of DNA methylation in age-related complex human traits. Epigenomics. 2012 Oct;4(5):511-26. doi: 10.2217/epi.12.45. Review.</citation>
    <PMID>23130833</PMID>
  </reference>
  <reference>
    <citation>Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, Sugarbaker DJ, Yeh RF, Wiencke JK, Kelsey KT. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009 Aug;5(8):e1000602. doi: 10.1371/journal.pgen.1000602. Epub 2009 Aug 14.</citation>
    <PMID>19680444</PMID>
  </reference>
  <reference>
    <citation>Day K, Waite LL, Thalacker-Mercer A, West A, Bamman MM, Brooks JD, Myers RM, Absher D. Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape. Genome Biol. 2013;14(9):R102.</citation>
    <PMID>24034465</PMID>
  </reference>
  <reference>
    <citation>Barrientos RM, Higgins EA, Biedenkapp JC, Sprunger DB, Wright-Hardesty KJ, Watkins LR, Rudy JW, Maier SF. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol Aging. 2006 May;27(5):723-32.</citation>
    <PMID>15893410</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>April 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2018</study_first_posted>
  <last_update_submitted>April 25, 2018</last_update_submitted>
  <last_update_submitted_qc>April 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Gen Shinozaki</investigator_full_name>
    <investigator_title>Associate Professor of Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

